We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Shield Therapeutics Plc | LSE:STX | London | Ordinary Share | GB00BYV81293 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.125 | 9.26% | 1.475 | 1.40 | 1.55 | 1.50 | 1.35 | 1.35 | 6,682,229 | 10:16:50 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 4.47M | -40.44M | -0.0522 | -0.28 | 11.24M |
Date | Subject | Author | Discuss |
---|---|---|---|
20/2/2024 16:27 | I see this is a usual trick played by mm, people are scared and selling your holding | qipincha | |
20/2/2024 15:54 | Good volume today, sadly.Death by a thousand cuts | reviewwworld | |
17/2/2024 13:28 | Nobbygnome - 30 Aug 2022 - 08:58:12 - 1542 of 1970 A few shorters will be panicking at this point ..... 😂 | thanatos abyss | |
16/2/2024 07:15 | Well With the scope Size of his Management team Greg needs to achieve something. But many years of disappointment and achievement I’m not expecting anything positive On certainty he will put a positive spin on a negative | best1467 | |
15/2/2024 14:49 | Fair enough then why did he say in the last statement."previous guidance" In the last update Greg said: 'I am pleased to report that the collaboration continues to deliver excellent results, based on the stand-out performance of the combined commercial team, which has produced consistent and strong sequential prescription growth and key performance indicators (KPI), which are trending towards previous guidance' | krp10 | |
15/2/2024 13:44 | They know their resultsThey are either, trying to get a couple more months data to soften blow of missing 100k prescriptions or waiting for some important other transaction or deal to happenNeither are attractive optionsI think it would be naive to imagine the CFO just starting is impacting this now and even more naive to think they blew 100k ..... they would have updated us asap | skcots48 | |
13/2/2024 11:46 | Shame they didn't take the opportunity to combine this event with the publication of Q4 results. Maybe Thursday or next week, ho hum. | bos1234 | |
13/2/2024 10:18 | hTTps://x.com/shield | chester9 | |
12/2/2024 10:24 | Yeah, cheers for that pearler. Everyone's an expert on share price movements - are they all multi-millionaires I wonder, and does a multi-millionaire spend her/his time on ADVFN churning out more wise owl predictions... | daveboy19 | |
12/2/2024 09:40 | 600 plus million shares in issue at 6p company is worth a lot of money Any miss on numbers and this will halve in no time | hamidahamida | |
08/2/2024 09:16 | All possible | qipincha | |
07/2/2024 13:36 | Hmm - some largish late reported trades from late yesterday at well above the then buy price.Someone in the know about the next update I wonder? | husbod | |
07/2/2024 07:29 | Tomorrow then ? | hatfullofsky | |
06/2/2024 21:56 | 100 sales staff tells me they are committed to commercial success | hatfullofsky | |
06/2/2024 17:48 | My notes show them saying Cash +tive 4Q25. This share price would more than likely already be 20p or more by now. However, when well on its way last time that idiot CEO started playing games. They need about 1-1.5% penetration in their market space to meet operating costs. 60% is their target objective $2.1Bn. Norgine, ASK Pharma, Korea Pharma and KYE Pharma and the association with VTRS mean they have fingers in global markets also. Hence, at some point this will all kick off; although with this CEO there is no knowing when that will be. | bolitix | |
06/2/2024 17:20 | Well, good opp to top up | qipincha | |
06/2/2024 17:05 | Locked and loaded, let's see what tomorrow brings GLAH | hatfullofsky | |
06/2/2024 17:04 | They've stated many times - Funded to break even in late 2024 / Cash flow positive by year end 2024 | hatfullofsky | |
06/2/2024 15:33 | This is a concern. I'm less worried about the update and more about another surprise fund raise & dilution being chucked in. What I actually want is someone to put us out of our misery and buy them at 15 to 20p. Can't see it happening though | skcots48 | |
06/2/2024 15:10 | I haven’t read the thread for months. The key element- the product, is still there. All other factors are just noises, given director purchased recently, there should be more confidence | qipincha | |
06/2/2024 14:15 | It seems to be a bit of a game at the moment and read it on another thread. Beat the price down to where they want it knowing any RNS should move it north again. Delay might happen re next update as waiting on approval news. | little minx | |
06/2/2024 13:09 | Sad thing is the share price would only get back to where it was with good news after the leaked fund raise at the massive disastrous discount. | chester9 | |
06/2/2024 13:07 | Hope I'm completely wrong and it's bucking the trend of insider trading but trading below 6p, down every single day, leads me to think the exponential growth has been put on ice the past quarter. | reviewwworld | |
05/2/2024 16:16 | Being a STX holder is testing me to the limit Absolute no idea which way this update is going. Clearly this 4Q result after the big move forward in 3Q is so important. They also have January which is traditionally a big month with often delayed Dec scripts pushed into Jan | skcots48 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions